Scientific article
English

ß-Lactam Monotherapy vs ß-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial

Published in

JAMA internal medicine, vol. 174, no. 12, p. 1894-1901

Publication date

2014

Abstract

The clinical benefit of adding a macrolide to a ß-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial.

Citation (ISO format)

GARIN, Nicolas et al. ß-Lactam Monotherapy vs ß-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. In: JAMA internal medicine, 2014, vol. 174, n° 12, p. 1894–1901. doi: 10.1001/jamainternmed.2014.4887

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

2168-6106
763views
0downloads

Technical informations

Creation

15/11/2014 13:54:00

First validation

15/11/2014 13:54:00

Update

13/10/2025 22:04:06

Status update

08/10/2024 09:17:18

Last indexation

10/11/2026 13:15:45
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated